Sukhi Thethy

Sukhi Thethy is Senior Vice President of Finance & Accounting at Chinook Therapeutics. Prior to Chinook, Sukhi was Vice President, Controller at Aimmune Therapeutics where she was responsible for and managed accounting operations, financial reporting and internal controls compliance, technical accounting, payroll and equity administration, revenue and cost accounting, tax compliance and treasury management. At Aimmune, Sukhi was part of the company’s growth from development to commercialization and participated in the sale of the company to Nestlé Health Science for $2.6 billion. Prior to Aimmune, Sukhi held various management roles at public biotech companies. Sukhi received her Master of Science in Accountancy from San Jose State University and is a Certified Public Accountant licensed in California.